Abstract:The performance as reinforcement of a fibrillar protein such as feather keratin fiber over a biopolymeric matrix composed of polysaccharides was evaluated in this paper. Three different kinds of keratin reinforcement were used: short and long biofibers and rachis particles. These were added separately at 5, 10, 15 and 20 wt% to the chitosan-starch matrix and the composites were processed by a casting/solvent evaporation method. The morphological characteristics, mechanical and thermal properties of the matrix and composites were studied by scanning electron microscopy, thermogravimetric analysis, differential scanning calorimetry and dynamic mechanical analysis. The thermal results indicated that the addition of keratin enhanced the thermal stability of the composites compared to pure matrix. This was corroborated with dynamic mechanical analysis as the results revealed that the storage modulus of the composites increased with respect to the pure matrix. The morphology, evaluated by scanning electron microscopy, indicated a uniform dispersion of keratin in the chitosan-starch matrix as a result of good compatibility between these biopolymers, also corroborated by FTIR. These results demonstrate that chicken feathers can be useful to obtain novel keratin reinforcements and develop new green composites providing better properties, than the original biopolymer matrix.

No abstract

Due to the high toxicity and side effects of the use of traditional chemotherapy in cancer, scientists are working on the development of alternative therapeutic technologies. An example of this is the use of death‑induced gene therapy. This therapy consists of the killing of tumor cells via transfection with plasmid DNA (pDNA) that contains a gene which produces a protein that results in the apoptosis of cancerous cells. The cell death is caused by the direct activation of apoptosis (apoptosis‑induced gene therapy) or by the protein toxic effects (toxin‑induced gene therapy). The introduction of pDNA into the tumor cells has been a challenge for the development of this therapy. The most recent implementation of gene vectors is the use of polymeric or inorganic nanoparticles, which have biological and physicochemical properties (shape, size, surface charge, water interaction and biodegradation rate) that allow them to carry the pDNA into the tumor cell. Furthermore, nanoparticles may be functionalized with specific molecules for the recognition of molecular markers on the surface of tumor cells. The binding between the nanoparticle and the tumor cell induces specific endocytosis, avoiding toxicity in healthy cells. Currently, there are no clinical protocols approved for the use of nanoparticles in death‑induced gene therapy. There are still various challenges in the design of the perfect transfection vector, however nanoparticles have been demonstrated to be a suitable candidate. This review describes the role of nanoparticles used for pDNA transfection and key aspects for their use in death‑induced gene therapy.

No abstract

Abstract: